Interestingly, BP1 expression was significantly increased in CML patients (P = 0.006), whereas DLX7 expression was markedly decreased (P = 0.001) (Fig. 1a). The gene discussed is DLX4; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.